respiratori
viral
infect
influenza
caus
larg
burden
morbid
mortal
worldwid
common
reason
patient
seek
medic
care
also
increasingli
recogn
caus
communityacquir
pneumonia
particularli
patient
older
underli
comorbid
chronic
obstruct
pulmonari
diseas
copd
immunocompromis
gadsbi
et
al
ruuskanen
et
al
clinic
present
nonspecif
accur
time
diagnost
critic
optim
antivir
use
limit
unnecessari
antibiot
reduc
secondari
spread
infect
older
diagnost
modal
serolog
viral
cultur
enzym
immunoassay
immunofluoresc
test
fraught
problem
like
poor
sensit
slow
turnaround
time
caliendo
mani
institut
reli
rapid
antigen
immunoassay
test
specif
produc
result
clinic
use
timefram
lack
sensit
unabl
detect
pathogen
limit
util
time
low
influenza
preval
brune
et
al
revolut
develop
commerci
dissemin
molecular
multiplex
assay
rapid
accur
detect
respiratori
virus
last
decad
major
step
forward
led
greater
appreci
ubiqu
contribut
mani
diseas
state
gaydo
gelfer
et
al
varkey
varkey
howev
set
routin
diagnost
microbiolog
laboratori
assay
labor
intens
implement
run
often
expens
mani
area
medicin
includ
modern
diagnost
microbiolog
laboratori
algorithm
approach
test
increasingli
use
maxim
advantag
minim
limit
cost
exampl
diagnosi
clostridium
difficil
infect
mani
lab
use
initi
highli
sensit
screen
test
follow
specif
secondari
confirmatori
molecular
assay
improv
overal
sensit
specif
costeffect
manner
makristathi
et
al
howev
approach
wide
studi
diagnosi
respiratori
viral
infect
one
studi
patient
influenza
combin
test
approach
shown
decreas
time
result
cost
antibiot
use
icu
admiss
increas
time
administr
oseltamivir
gonzalezdel
vecchio
et
al
increas
pressur
hospit
system
diagnos
treat
quickli
discharg
patient
rapid
accur
diagnost
test
critic
mind
multiplex
pcr
introduc
institut
prior
influenza
season
part
test
algorithm
replac
viral
cultur
aim
retrospect
cohort
diagnost
microbiolog
infecti
diseas
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
g
c
r
b
studi
evalu
perform
twostag
test
approach
term
diagnost
perform
timeli
cost
studi
popul
includ
patient
children
adult
test
respiratori
viral
infect
tuft
medic
center
academ
medic
center
approxim
adult
pediatr
bed
boston
massachusett
decemb
decemb
case
identifi
search
electron
medic
record
posit
neg
test
result
patient
test
respiratori
viral
pathogen
patient
could
includ
test
episod
consid
independ
sampl
exclud
process
usual
algorithm
final
result
equivoc
data
collect
patient
age
test
locat
time
nasopharyng
swab
collect
test
perform
final
result
time
result
releas
tuft
medic
center
institut
review
board
approv
studi
inform
consent
requir
given
minim
risk
retrospect
natur
nasopharyng
flock
swab
collect
patient
clinic
suspect
respiratori
viral
infect
train
nurs
medic
personnel
transport
laboratori
ml
remel
multimicrob
media
thermofish
scientif
lenexa
ks
usa
via
autom
rapid
transit
system
winter
period
mid
decemb
april
increas
influenza
preval
sampl
first
test
immunoassay
quidel
corpor
san
diego
ca
usa
influenza
also
rsv
children
year
old
request
sofia
influenza
ab
fia
packag
insert
sampl
test
posit
undergo
test
neg
sampl
subsequ
test
summer
month
mayearli
decemb
specimen
test
biofir
biofir
diagnost
salt
lake
citi
compani
marci
letoil
franc
alon
respiratori
panel
packag
insert
clinician
order
respiratori
viral
panel
specif
test
perform
determin
laboratori
standard
fashion
manufactur
instruct
follow
test
procedur
protocol
variat
respiratori
viral
test
perform
sampl
repeat
test
permit
clinic
indic
rare
perform
within
episod
care
fluoresc
immunoassay
rapid
rel
inexpens
later
flow
assay
influenza
b
report
high
specif
low
sensit
compar
molecular
assay
brune
et
al
gomez
et
al
hazelton
et
al
noh
et
al
requir
less
minut
handson
setup
time
minut
runtim
separ
test
avail
rsv
biofir
modern
simpl
fast
accur
multiplex
pcrbase
test
capabl
detect
multipl
respiratori
virus
includ
influenza
b
parainfluenza
human
metapneumoviru
human
rhinovirusenteroviru
coronavirus
adenoviru
respiratori
syncyti
viru
rsv
well
bacteria
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
requir
maximum
minut
handson
prepar
time
around
minut
runtim
sensit
specif
test
report
studi
depend
pathogen
respiratori
panel
packag
insert
unlik
batch
assay
one
patient
sampl
test
per
instrument
given
time
studi
period
onsit
microbiolog
laboratori
staf
midnight
test
perform
hour
two
instrument
use
use
test
midnight
test
alon
perform
hematolog
laboratori
although
perform
point
care
institut
perform
laboratori
given
avail
rapid
specimen
transport
signific
burden
maintain
multipl
instrument
train
staff
outsid
laboratori
basic
descript
statist
calcul
categor
data
report
percentag
continu
data
mean
standard
deviat
normal
distribut
median
rang
nonnorm
distribut
miss
data
variabl
interest
neglig
purpos
analysi
final
test
result
categor
group
neg
posit
influenza
posit
rsv
posit
viru
categor
variabl
compar
use
chisquar
test
odd
ratio
associ
p
valu
calcul
use
univari
logist
regress
kaplanmei
cumul
incid
curv
gener
repres
time
result
data
compar
use
logrank
test
p
b
consid
statist
signific
unfortun
sensit
specif
could
accur
calcul
patient
test
posit
undergo
confirmatori
test
though
suffici
data
avail
calcul
neg
predict
valu
npv
use
gold
standard
analys
perform
r
statist
softwar
platform
version
rstudio
version
cost
estim
base
cost
per
test
laboratori
total
test
episod
uniqu
patient
identifi
seven
exclud
sampl
process
pathway
appropri
result
equivoc
leav
episod
patient
final
analysi
median
age
time
test
year
rang
year
patient
male
patient
less
year
old
specimen
commonli
receiv
inpati
unit
n
follow
ambulatori
clinic
n
emerg
room
n
bed
outpati
n
employe
health
n
outpati
dialysi
n
sampl
process
winter
via
algorithm
compar
summer
underw
one
pathogen
detect
case
throughout
studi
period
overal
test
posit
result
final
diagnos
obtain
stratifi
test
season
shown
tabl
patient
test
algorithm
diagnos
case
influenza
influenza
influenza
b
rsv
includ
patient
test
posit
influenza
rsv
result
shown
fig
patient
neg
sofia
influenza
antigen
went
posit
influenza
influenza
influenza
b
rsv
includ
patient
influenza
rsv
anoth
viru
mycoplasma
pneumonia
overal
patient
diagnos
influenza
test
neg
test
rsv
perform
patient
children
year
old
request
other
neg
rsv
posit
addit
case
rsv
diagnos
amongst
patient
antigen
test
perform
also
posit
influenza
neg
predict
valu
averag
preval
across
whole
period
test
influenza
rsv
specimen
collect
time
avail
sampl
test
winter
summer
kaplanmei
curv
compar
two
time
period
shown
fig
two
curv
look
similar
overal
significantli
higher
proport
final
test
result
avail
less
minut
winter
compar
summer
due
use
faster
antigen
test
season
versu
odd
ratio
confid
interv
p
b
correspond
case
influenza
case
rsv
diagnosi
made
less
minut
comparison
time
result
test
type
patient
test
use
algorithm
shown
fig
b
median
time
result
hour
interquartil
rang
iqr
hour
posit
compar
hour
iqr
hour
patient
went
p
b
base
cost
individu
test
laboratori
alon
perform
sampl
total
cost
influenza
season
would
addit
instead
avoid
patient
posit
respiratori
viru
less
expens
test
prior
onset
influenza
season
decis
made
introduc
new
respiratori
viral
test
algorithm
diagnost
microbiolog
laboratori
goal
combin
benefit
inexpens
rapid
specif
test
accuraci
sensit
one
reduc
overal
fals
neg
rate
retrospect
evalu
perform
protocol
chang
describ
signific
benefit
term
overal
perform
timeli
cost
varieti
test
approach
includ
use
viral
cultur
older
batch
multiplex
molecular
assay
describ
studi
first
evalu
approach
modern
era
use
new
ondemand
molecular
diagnost
test
cohort
perform
antigen
test
sampl
would
miss
case
influenza
rsv
although
may
diagnos
usag
rsv
antigen
influenzarsv
coinfect
virus
case
pneumonia
convers
use
alon
sampl
case
influenza
rsv
case
influenzarsv
coinfect
would
diagnos
delay
least
sever
hour
signific
addit
cost
despit
process
almost
twice
mani
specimen
winter
median
time
result
similar
summer
significantli
higher
number
final
result
avail
hour
diagnost
algorithm
test
strategi
describ
mani
advantag
firstli
decreas
overal
turnaround
time
busi
winter
month
hour
time
save
may
seem
like
much
result
avail
within
timefram
mean
test
much
like
use
realtim
clinic
decisionmak
context
busi
emerg
depart
outpati
set
facilit
rapid
diagnosi
influenza
rsv
would
hope
translat
earlier
administr
antivir
therapi
signific
therapeut
benefit
aoki
et
al
could
decreas
use
unnecessari
antibiot
addit
could
mean
earlier
initi
appropri
infect
control
precaut
reduc
secondari
transmiss
effect
amplifi
appli
across
mani
patient
secondli
maxim
diagnost
accuraci
influenza
also
detect
mani
respiratori
viral
pathogen
clinic
indistinguish
provid
patient
clinician
clariti
definit
microbiolog
diagnosi
reassur
favor
prognosi
like
without
need
antibiot
furthermor
due
differ
transmiss
characterist
respiratori
pathogen
cdc
guidelin
isol
precaut
differ
diagnosi
siegel
et
al
identifi
specif
pathogen
may
increas
likelihood
appropri
precaut
implement
reduc
nosocomi
transmiss
final
facilit
increas
test
volum
within
exist
laboratori
technician
time
constraint
requir
input
order
clinician
may
familiar
nuanc
differ
respiratori
viral
test
avail
use
laboratorybas
test
rather
true
pointofcar
test
increas
turnaround
time
somewhat
minim
locat
onsit
laboratori
rapid
specimen
transport
system
obviat
need
train
nonlaboratori
base
staff
maintain
instrument
outsid
diagnost
laboratori
like
diagnost
test
approach
potenti
drawback
approach
consid
fals
posit
result
antigen
test
clearli
occur
could
lead
misdiagnosi
unnecessari
administr
oseltamivir
potenti
miss
altern
diagnosi
patient
test
posit
sofia
could
coinfect
second
viru
unlik
signific
impact
manag
decis
outcom
bacteri
pathogen
miss
could
lead
failur
prescrib
antibiot
rate
bacteri
pathogen
studi
low
mani
patient
receiv
empir
antibiot
despit
diagnosi
viru
cover
possibl
secondari
bacteri
infect
minim
risk
error
occur
recommend
perform
test
influenza
season
preval
high
minim
fals
posit
rate
make
individu
decis
regard
use
antibiot
incorpor
avail
clinic
data
backup
molecular
test
avail
clinician
request
difficult
case
strength
studi
evalu
diagnost
strategi
larg
cohort
patient
busi
influenza
season
realworld
context
howev
limit
consid
interpret
find
measur
clinic
outcom
downstream
effect
beyond
scope
studi
howev
publish
studi
demonstr
clinic
impact
variou
molecular
diagnost
test
shown
earlier
antivir
use
decreas
ed
hospit
length
stay
reduc
secondari
transmiss
decreas
antibiot
use
aoki
et
al
chu
et
al
gelfer
et
al
mayer
et
al
would
anticip
similar
impact
patient
popul
time
howev
requir
privat
room
cohort
patient
found
respiratori
virus
requir
isol
previous
would
gone
undiagnos
undoubtedli
result
costli
throughput
issu
consider
must
underestim
patient
test
posit
undergo
test
could
determin
true
sensit
specif
test
compar
previou
studi
shown
specif
high
recent
metaanalysi
report
pool
specif
sensit
influenza
b
pool
specif
sensit
rsv
brune
et
al
gomez
et
al
hazelton
et
al
noh
et
al
similarli
assum
patient
test
neg
pcr
true
neg
possibl
patient
could
fals
neg
test
ie
sensit
truli
find
like
generaliz
hospitalbas
clinic
microbiolog
laboratori
perform
affect
number
sitespecif
variabl
includ
test
volum
number
instrument
affect
abil
perform
test
parallel
therefor
queu
staf
choic
specif
rapidmolecular
test
mani
option
commerci
avail
final
formal
costeffect
analysi
incorpor
secondari
cost
laboratori
technician
time
hospit
drug
cost
beyond
scope
studi
could
consid
fulli
evalu
test
strategi
rel
other
financ
within
us
healthcar
system
particularli
complex
given
intrahospit
budget
silo
actual
bill
reimburs
charg
oppos
cost
reagentinstru
rental
deal
purchas
arrang
mani
factor
need
consid
fulli
understand
econom
implic
approach
new
multiplex
pcr
assay
biofir
revolutionari
leap
forward
microbiolog
laboratori
base
diagnosi
respiratori
viral
infect
ondemand
test
signific
advantag
older
multiplex
pcr
platform
often
requir
batch
special
personnel
establish
run
howev
like
test
shortcom
includ
cost
inabl
handl
simultan
test
multipl
sampl
find
demonstr
simpl
way
maxim
perform
test
use
combin
test
approach
rapid
immunoassay
array
licens
rapid
molecular
diagnost
test
respiratori
viral
infect
increas
includ
avail
use
point
care
hospit
need
care
consid
best
test
approach
base
local
epidemiolog
avail
resourc
combin
test
approach
describ
one
way
optim
diagnost
perform
minim
limit
includ
cost
individu
test
work
support
tuft
medic
center
divis
geograph
medicin
infecti
diseas
franci
p
talli
md
fellowship
author
report
potenti
conflict
interest
